Aptevo Therapeutics Inc. Liquidation Value
APVO
Other
Cash & Equivalents
$21.62M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $21.62M
Total Obligations: -$10.68M
$10.94M
Per share: $10.96
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $21.62M
AR: $0
Total Obligations: -$10.68M
$10.94M
Per share: $10.96
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $21.62M
AR: $0
Inventory: $0
Total Obligations: -$10.68M
$10.94M
Per share: $10.96
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $10.94M | $10.96 |
| Liquid Liquidation Value | $10.94M | $10.96 |
| Operating Liquidation Value | $10.94M | $10.96 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $21.62M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $6.05M |
| Long-term Debt | N/A |
| Op. Lease Liability | $4.63M |
| Finance Lease | N/A |
| Shares Outstanding | 997,830 |
Explore all 121 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $21.62M | N/A | N/A | $877,000 | $6.05M | N/A | $4.63M | N/A |
| 2025-09-30 | $21.06M | N/A | N/A | N/A | $5.61M | N/A | $4.79M | N/A |
| 2025-06-30 | $9.41M | N/A | N/A | N/A | $4.89M | N/A | $5.01M | N/A |
▼ Community Notes